Early Population-Level Impact of Helicobacter pylori Eradication on Gastric Cancer Deaths in Japan: A Counterfactual Analysis of Short-Term Divergence
This study demonstrates that the nationwide expansion of *Helicobacter pylori* eradication therapy in Japan since 2013 has already contributed to a 10.4% reduction in gastric cancer deaths by 2021, preventing an estimated 1,427 deaths through a counterfactual analysis framework that accounts for the disease's long natural history.